1. Home
  2. BWAY vs EXFY Comparison

BWAY vs EXFY Comparison

Compare BWAY & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • EXFY
  • Stock Information
  • Founded
  • BWAY 2003
  • EXFY 2008
  • Country
  • BWAY Israel
  • EXFY United States
  • Employees
  • BWAY N/A
  • EXFY N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • BWAY Health Care
  • EXFY Technology
  • Exchange
  • BWAY Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • BWAY 201.1M
  • EXFY 206.1M
  • IPO Year
  • BWAY 2019
  • EXFY 2021
  • Fundamental
  • Price
  • BWAY $10.96
  • EXFY $2.40
  • Analyst Decision
  • BWAY Strong Buy
  • EXFY Strong Buy
  • Analyst Count
  • BWAY 2
  • EXFY 3
  • Target Price
  • BWAY $14.25
  • EXFY $4.75
  • AVG Volume (30 Days)
  • BWAY 33.7K
  • EXFY 444.1K
  • Earning Date
  • BWAY 08-05-2025
  • EXFY 08-07-2025
  • Dividend Yield
  • BWAY N/A
  • EXFY N/A
  • EPS Growth
  • BWAY N/A
  • EXFY N/A
  • EPS
  • BWAY 0.08
  • EXFY N/A
  • Revenue
  • BWAY $43,457,000.00
  • EXFY $141,775,000.00
  • Revenue This Year
  • BWAY $351.53
  • EXFY $7.77
  • Revenue Next Year
  • BWAY $21.84
  • EXFY $5.45
  • P/E Ratio
  • BWAY $54.48
  • EXFY N/A
  • Revenue Growth
  • BWAY 26.86
  • EXFY N/A
  • 52 Week Low
  • BWAY $5.67
  • EXFY $1.26
  • 52 Week High
  • BWAY $12.00
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 58.38
  • EXFY 51.05
  • Support Level
  • BWAY $10.81
  • EXFY $2.19
  • Resistance Level
  • BWAY $11.40
  • EXFY $2.33
  • Average True Range (ATR)
  • BWAY 0.46
  • EXFY 0.11
  • MACD
  • BWAY -0.03
  • EXFY 0.02
  • Stochastic Oscillator
  • BWAY 50.88
  • EXFY 69.01

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

Share on Social Networks: